NewYork-Presbyterian Advances
NewYork-Presbyterian, with doctors from Columbia and Weill Cornell Medicine, is on the forefront of groundbreaking research, medical innovation, and advanced patient care. NYP Advances is a go-to resource for medical professionals looking to stay up to date on the latest research, clinical trials, education and more through a wide range of sources.
Featured Updates
On this episode of Advances in Care, Erin Welsh is joined by Dr. Lawrence Lustig, Chair of Otolaryngology–Head & Neck Surgery at NewYork-Presbyterian and Columbia. Dr. Lustig has spent decades working to advance various interventions to treat genetic hearing loss and after years of research his team was the first to show that gene therapies could be effective at reversing genetic hearing loss in mouse models and eventually, humans. In April 2026, the FDA approved the first ever gene therapy for genetic deafness based on the work pushed forward by Dr. Lustig.
What Sets Us Apart
¹ 19,474 lifetime transplants as of 3/31/2024 and largest transplant hospital for 2021-2023, OPTN | ² 2023-2024 U.S. News and World Report, Top 50 Cardiology, Heart & Vascular Surgery Ranking
Innovations in Review
Oncology (Cancer)
Meet Our Doctors
The emergency physician-in-chief at NewYork-Presbyterian and Weill Cornell Medicine shares how he incorporated telehealth into emergency care and discusses the importance of training doctors to provide the best virtual care.
Videos
Dr. Wakenda Tyler, chief of orthopedic oncology at NewYork-Presbyterian and Columbia, describes the unique orthoplastics model she and her team developed for soft tissue sarcoma and how it has led to an increase in limb-sparing surgeries.
Advances in Care Podcast
Advancing the Field of Medicine
Clinical Trials
We are world leaders when it comes to advancing science and clinical research. Learn more about the studies we currently have underway.
Continuing Medical Education
We offer a wide range of CME courses to help doctors, nurses and other clinicians stay at the forefront of their fields.























